When do you consider complement inhibitors or FcRN inhibitors in patients with myasthenia gravis?  

These are new medications and, to my knowledge, there is no agreed-upon standardized approach as to when they should be used.



Answer from: at Academic Institution
Comments
at UPMC
Thank you! Nicely done.
Sign in or Register to read more

Answer from: at Community Practice
Comments
at Columbia University Medical Center, New York
Another thoughtful response that highlights the sp...
at Clinical Professor of Medicine
Drs. @Manousakis and @Lewis shed light on some of ...
Sign in or Register to read more